Artiva Biotherapeutics, Inc.
$11.09
-0.85 (-7.12%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +6.3%
- 3 Months
- +39.8%
- YTD
- +158.5%
- 1 Year
- +239.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 183.6%
- Largest decline max drawdown, since Aug 2025
- -49.2%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.34
Own ARTV?
See how ARTV contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.